Overview

* Global Medical REIT ( GMRE ) Q2 rental revenue up 10.7% yr/yr due to acquisitions

* Company completes $69.6 mln acquisition of five-property medical portfolio

* Co reaffirms full year 2025 AFFO guidance

Outlook

* Company reaffirms full-year 2025 AFFO guidance of $0.89 to $0.93 per share

* Company expects to complete refinancing of $350 mln Term Loan A by Q4 2025

Result Drivers

* ACQUISITIONS - Rental revenue increased 10.7% yr/yr primarily due to acquisitions completed after June 2024

* LEASE OCCUPANCY - Full occupancy of Beaumont, TX facility by CHRISTUS Health contributed to revenue

* EXPENSE INCREASE - Higher G&A costs linked to CEO succession plan and acquisition-related expenses

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 $37.88

Rental mln

Revenue

Q2 Net $585,000

Income

Q2 $16.60

Adjusted mln

FFO

Q2 FFO $14.26

mln

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 5 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the specialized reits peer group is "buy"

* Wall Street's median 12-month price target for Global Medical REIT Inc ( GMRE ) is $8.75, about 23.5% above its August 4 closing price of $6.69

* The stock recently traded at 51 times the next 12-month earnings vs. a P/E of 105 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)